These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 879760
1. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Eriksson B, Helgstrand E, Johansson NG, Larsson A, Misiorny A, Norén JO, Philipson L, Stenberg K, Stening G, Stridh S, Oberg B. Antimicrob Agents Chemother; 1977 Jun; 11(6):946-51. PubMed ID: 879760 [Abstract] [Full Text] [Related]
6. Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction. Fernandez-Larsson R, O'Connell K, Koumans E, Patterson JL. Antimicrob Agents Chemother; 1989 Oct; 33(10):1668-73. PubMed ID: 2556073 [Abstract] [Full Text] [Related]
7. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Wray SK, Gilbert BE, Knight V. Antiviral Res; 1985 Feb; 5(1):39-48. PubMed ID: 3985607 [Abstract] [Full Text] [Related]
8. Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses. Wray SK, Smith RH, Gilbert BE, Knight V. Antimicrob Agents Chemother; 1986 Jan; 29(1):67-72. PubMed ID: 3729336 [Abstract] [Full Text] [Related]
9. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J. PLoS One; 2013 Jan; 8(7):e68347. PubMed ID: 23874596 [Abstract] [Full Text] [Related]
10. Studies on the mechanism of the antiviral activity of ribavirin against reovirus. Rankin JT, Eppes SB, Antczak JB, Joklik WK. Virology; 1989 Jan; 168(1):147-58. PubMed ID: 2909988 [Abstract] [Full Text] [Related]
11. Altered ATP function of a vesicular stomatitis virus mutant detected by kinetic analysis of the transcriptase using phosphorylated ribavirin. Fernandez-Larsson R, Patterson JL. J Gen Virol; 1989 Oct; 70 ( Pt 10)():2791-7. PubMed ID: 2552007 [Abstract] [Full Text] [Related]
13. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Müller WE, Maidhof A, Taschner H, Zahn RK. Biochem Pharmacol; 1977 Jun 01; 26(11):1071-5. PubMed ID: 880258 [No Abstract] [Full Text] [Related]
14. Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase. Bougie I, Bisaillon M. J Biol Chem; 2003 Dec 26; 278(52):52471-8. PubMed ID: 14563844 [Abstract] [Full Text] [Related]
15. Reversible inhibition of cellular metabolism by ribavirin. Larsson A, Stenberg K, Oberg B. Antimicrob Agents Chemother; 1978 Feb 26; 13(2):154-8. PubMed ID: 646339 [Abstract] [Full Text] [Related]
16. Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus. Smee DF, Alaghamandan HA, Kini GD, Robins RK. Antiviral Res; 1988 Dec 11; 10(6):253-62. PubMed ID: 2854956 [Abstract] [Full Text] [Related]
17. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W. Cancer Res; 1985 Nov 11; 45(11 Pt 1):5512-20. PubMed ID: 2865005 [Abstract] [Full Text] [Related]